ANNE L. ANGIOLILLO
Medical Practice in Washington, DC
License number
DC MD19255
Category
MEDICINE
Type
MEDICINE AND SURGERY
Address
Address
Washington, DC
Organization information
See more information about ANNE L. ANGIOLILLO at bizstanding.comChildren's National Medical Center - Anne L Angiolillo MD
111 Michigan Ave NW #4043, Washington, DC 20010
Categories:
Pediatrics Physicians & Surgeons
Phone:
(202) 476-2800 (Phone)
Professional information
Dr. Anne L Angiolillo, Washington DC - MD (Doctor of Medicine)
Specialties:
Pediatric Hematology & Oncology
Address:
CHILDRENS NATIONAL MED CTR
111 Michigan Ave NW, Washington 20010
(202) 884-5000 (Phone), (202) 884-5700 (Fax)
Chldrns Natl Med Ctr Hema/Onc
111 Michigan Ave NW SUITE 4043, Washington 20010
(202) 476-2800 (Phone)
111 Michigan Ave NW, Washington 20010
(202) 884-5000 (Phone), (202) 884-5700 (Fax)
Chldrns Natl Med Ctr Hema/Onc
111 Michigan Ave NW SUITE 4043, Washington 20010
(202) 476-2800 (Phone)
Certifications:
Pediatric Oncology & Pediatric Hematology, 1996, Pediatrics, 1993
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
New York Medical College
Graduated: 1989
Children's National Med Center
Geo Washington University School Med
New York Medical College
Graduated: 1989
Children's National Med Center
Geo Washington University School Med
Anne Angiolillo, Washington DC
Work:
Children's National Medical Center
111 Michigan Ave NW, Washington, DC 20010
111 Michigan Ave NW, Washington, DC 20010
Anne L Angiolillo, Washington DC
Specialties:
Pediatric Hematologist / Oncologist
Address:
111 Michigan Ave Nw, Washington, DC 20010
Education:
New York Medical College - Doctor of Medicine
Board certifications:
American Board of Pediatrics Sub-certificate in Pediatric Hematology/Oncology (Pediatrics)
Interferon-Inducible Protein 10 Is A Potent Inhibitor Of Angiogenesis
US Patent:
5994292, Nov 30, 1999
Filed:
May 31, 1995
Appl. No.:
8/455079
Inventors:
Giovanna Tosato - Bethesda MD
Anne L. Angiolillo - Washington DC
Cecilia Sgadari - Bethesda MD
Anne L. Angiolillo - Washington DC
Cecilia Sgadari - Bethesda MD
Assignee:
The United States of America as represented by the Department of Health
and Human Services - Washington DC
and Human Services - Washington DC
International Classification:
A61K 3800
US Classification:
514 2
Abstract:
The present invention is interferon-inducible protein 10 and fragments and analogs of interferon-inducible protein 10 as inhibitors of angiogenesis. The present invention is also the use of interferon-inducible protein 10 (IP-10) as well as fragments and analogs of IP-10 as potent inhibitors of angiogenesis. IP-10 profoundly inhibited basic fibroblast growth factor (bFGF)-induced neovascularization in immunocompromised mammals. In addition, IP-10, is useful in a dose-dependent fashion in suppressing endothelial cell differentiation into tubular capillary structures.